MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/iju.70391

Медицинская библиотека · International journal of urology : official journal of the Japanese Urological Association · 2026

Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.

Iida Kota, Hayashi Yuriko, Narita Kosuke, Itami Yoshitaka, Morimoto Hideyuki, Ishii Kentaro, Itagaki Yasushi, Hosokawa Yukinari, Fujimoto Kiyohide

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Hypofractionated radiotherapy for prostate cancer has recently gained attention, with growing evidence supporting the clinical use of hypofractionation. This retrospective study aimed to compare the outcomes of hypofractionated radiotherapy with conventional fractionation.

METHODS

Between 2012 and 2021, patients with low- or intermediate-risk prostate cancer treated at our institution were included. Patients were divided into two groups: the conventional group (78.0 Gy in 39 fractions over 8 weeks) and the hypofractionated group (51.6 Gy in 12 fractions over 2.5 weeks). Survival outcomes and toxicities were compared between the two groups.

RESULTS

A total of 96 patients were included: 54 in the conventional group and 42 in the hypofractionated group. The median follow-up time was 110.5 months (IQR: 78.3-125.0) in the conventional group and 73.5 months (IQR: 57.8-83.5) in the hypofractionated group. Only one patient in the conventional group experienced biochemical recurrence. There were no significant differences in acute grade ≥ 2 urinary or bowel toxicity between the two groups. Grade ≥ 2 late urinary toxicity was more frequent in the hypofractionated group (16.7% vs. 7.4%, p = 0.16), while grade ≥ 2 late bowel toxicity was more frequent in the conventional group (16.7% vs. 4.8%, p = 0.07).

CONCLUSIONS

Hypofractionated radiotherapy demonstrated comparable oncological outcomes and an acceptable toxicity profile to those of conventionally fractionated radiotherapy in patients with low- to intermediate-risk prostate cancer.

Для цитирования: Iida Kota, Hayashi Yuriko, Narita Kosuke, Itami Yoshitaka, Morimoto Hideyuki, Ishii Kentaro, Itagaki Yasushi, Hosokawa Yukinari, Fujimoto Kiyohide. Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.. International journal of urology : official journal of the Japanese Urological Association. 2026. DOI: 10.1111/iju.70391.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.